cetirizine dihydrochloride (rescue medication) is one of 26 small molecule programs targeting Seasonal Allergic Rhinitis. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
25 competitors in Seasonal Allergic Rhinitis
Zyrtec
Allegra
Clarinex
Flovent
Claritin
Asmanex Hfa
Singulair
Xyzal
Kenalog
Adrenaline
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details